0K05.L - Medifast, Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3-55.11%
S&P500 52-week change 314.65%
52-week high 3189.75
52-week low 378.81
50-day moving average 391.36
200-day moving average 3116.50

Share statistics

Avg vol (3-month) 3111
Avg vol (10-day) 3124
Shares outstanding 511.96M
Implied shares outstanding 6N/A
Float 89.94M
% held by insiders 11.99%
% held by institutions 188.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 36.57
Trailing annual dividend yield 37.88%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 9.27%
Operating margin (ttm)11.98%

Management effectiveness

Return on assets (ttm)30.82%
Return on equity (ttm)73.27%

Income statement

Revenue (ttm)1.53B
Revenue per share (ttm)138.81
Quarterly revenue growth (yoy)-16.40%
Gross profit (ttm)1.14B
EBITDA 194.74M
Net income avi to common (ttm)141.76M
Diluted EPS (ttm)14.02
Quarterly earnings growth (yoy)-4.30%

Balance sheet

Total cash (mrq)123.75M
Total cash per share (mrq)11.48
Total debt (mrq)24.38M
Total debt/equity (mrq)14.26
Current ratio (mrq)1.75
Book value per share (mrq)15.85

Cash flow statement

Operating cash flow (ttm)214.96M
Levered free cash flow (ttm)166.72M